Alterity Therapeutics Limited Share Price
Equities
ATH
AU0000043945
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.006 AUD | 0.00% | 0.00% | -14.29% |
16/04 | ADRs End Lower, Purple Biotech Ltd. Declines 29% | DJ |
12/04 | ADRs End Lower, Leju Holdings Ltd. Declines 72% | DJ |
Sales 2024 * | 1.87M 2.86M 156M | Sales 2025 * | 1.39M 2.13M 116M | Capitalization | 20.5M 31.38M 1.71B |
---|---|---|---|---|---|
Net income 2024 * | -8M -12.25M -667M | Net income 2025 * | -10M -15.31M -834M | EV / Sales 2024 * | 11 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 14.7 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.93% |
Latest transcript on Alterity Therapeutics Limited
Current month | +20.00% | ||
1 month | +33.33% | ||
3 months | +20.00% | ||
6 months | -14.29% | ||
Current year | -14.29% |
Managers | Title | Age | Since |
---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 63 | 01/17/01 |
Geoffrey Kempler
FOU | Founder | 69 | 11/97/11 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Kempler
FOU | Founder | 69 | 11/97/11 |
Peter Marks
BRD | Director/Board Member | 68 | 29/05/29 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 08/11/08 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.006 | 0.00% | 3,782,324 |
24/24/24 | 0.006 | 0.00% | 28,034,900 |
23/24/23 | 0.006 | +9.09% | 7,029,993 |
22/24/22 | 0.0055 | -8.33% | 1,381,828 |
19/24/19 | 0.006 | +20.00% | 5,042,183 |
Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.29% | 20.5M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ATH Stock